Abstract P324: Clinical Outcomes And 30-day Readmissions For Heart Failure With Preserved Ejection Fraction And Cardiorenal Syndrome: A Multicenter Database Analysis

Abstract only Background: Literature regarding cardiorenal syndrome (CRS) outcomes among heart failure with preserved ejection fraction (HFpEF) is limited. Objective: This study sought to characterize CRS patients' clinical outcomes and 30-day readmission rates with HFpEF. Methods: Data was col...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2022-09, Vol.79 (Suppl_1)
Main Authors: Shanah, Layla, Mir, Tanveer, Uddin, Mohammed, Hussain, Tanveer, Parajuli, Tilachan, Bhat, Zeenat Y
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract only Background: Literature regarding cardiorenal syndrome (CRS) outcomes among heart failure with preserved ejection fraction (HFpEF) is limited. Objective: This study sought to characterize CRS patients' clinical outcomes and 30-day readmission rates with HFpEF. Methods: Data was collected from the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project (HCUP) Nationwide Readmissions Database (NRD) from January 1, 2018, to November 30, 2019. We used the International Classification of Diseases, 10 th revision (ICD-10) diagnostic codes to identify encounters with CRS related to HFpEF. Results: Out of the 1,530,749 index HFpEF-CRS related hospitalizations (mean age 74.44±12.42years; 56.7%females), 1,295,302(82.1%) had CKD stage I-IV and 281,689(17.9%) had CKD stage V+. The CKD I-IV+ group had higher multi-organ complications including atrial fibrillation (AF) (33.7% vs 21.1%; p-value
ISSN:0194-911X
1524-4563
DOI:10.1161/hyp.79.suppl_1.P324